Biotecan Biology , A Leading Company in Precision Medicine
  • Strategic Collaboration
  • Business Collaboration
  • Call for bids
  •  Since Biotecan has been founded in 2008, we have been driving innovation in precision medicine and revolutionizing the future of China’s healthcare management. Biotecan has an unparalleled team of medical experts from around the world. We use the most advanced technology to create a network between hospitals, molecular medical centers, and patients, designed to make precision medicine healthcare available to everyone, everywhere.  With the joint efforts of Fudan University and Zhangjiang Translational Center, Biotecan established a Shanghai Precision Medical Big Data Cloud Computing Center based on clinical samples and medical information on leading diseases in China. As an important milestone in the development of precision medicine, Biotecan will collaborate with Shanghai Chest Hospital to build a Lung Cancer Precision Medicine Medical Research Center, and work with the Tenth Affiliated Hospital of Tongji University to found a Precision Medical Center. These medical centers will lead to the industrialization of systematic Precision Medical solutions for translational medical research in China. Each molecular medical center will focus on clinical application, supported by the development of large-scale intelligent clinical medical data bank, omics bioinformation, social and psychological factors in medical data processing, analytics and deep data mining to create a comprehensive digital engine. The national network of molecular diagnostic centers that Biotecan has across China will serve as the foundation to China’s largest Medical Big Data Center.

    58PIC9x58PICXrA_1024.jpg


    Precision Medical Big Data Center (Current Achievements)

    “Biological Big Data Development and Key Technology Research” funded by the National 863 Program

    Establishment and standardization of the “Esophageal Cancer Clinical Decision Support System”

    Initial Construction of “Precision Medicine Clinical Decision Support System”

    As of now, the Collaborative Research Hospital network has covered all major cities in China

    Precision Medicine Big Data Center (Research Goals)

    To build the first complete data bank of clinical information and illness-related information unique to the Chinese population.

    To construct a large-scale multidimensional medical bioinformation analytical engine and cloud computing system, and to become the leading medical bioinformation cloud computing technological solutions provider in the world.

    To create the world’s largest Medical Big Data Industrialization network and to build joint molecular medical research centers across China.


    We are seeking for cooperation in these four areas:

    1、Hospitals:

    Joint Molecular Centers are crucial to the development of Medical Big Data. Though the standardization of clinical research systems in medical departments, we offer technical support for hospitals in the integration of clinical data and scientific research. Biotecan will assist you in the application of research grants and publication of research papers every step of the way. 。

      Initial Construction of Joint Molecular Diagnostic Centers will include the following 3 functions:

      1)1.Internationally and domestically certified Clinical Molecular Diagnostics Laboratory: Biotecan will invest in the purchase and installation of world-class medical equipment and supply technology with independent intellectual property rights. In addition, we will install supporting computer software, hardware, and a large database within the laboratory. This will provide your hospital with a complete solution to clinical molecular diagnosis and research.

      2)Co-build a first-class Luxury Health Care and Management Center that uses the Next Generation Sequencing technology. The Joint Healthcare Center will provide a personalized healthcare and management solution according to each patient’s individual genetic characteristics. We will establish a standard health data mining system and a follow-up system as the foundation for the construction of the Medical Big Data Center.

      3)3.Construct a large-scale clinical disease database, reference genome database, data processing system, data mining system and a system to generate of automated medical report. We will also build a mobile client service terminal within the medical cloud computing center, in effort to support the association study of clinical data in genomics, proteomics, metabolomics and such.

      Following the construction of the Joint Molecular Diagnostic Center, we hope to create a high-end brand for the hospital, and build a self-sustaining model that is based on the advantages of each hospital specialization in medicine, and will mainly serve 3 functions below:

      1)1.Offer molecular diagnostics service for the hospital’s surrounding cities and provinces, including services such as disease-related genetic tests, qualitative analysis, CTC monitoring, and infectious disease pathogen detection to improve the overall level of the hospital’s diagnosis.

      2)2.Provide a supporting professional medical team as well as a hardware and software platform for the clinical R&D department. The standard construction of clinical research base and research mechanism in each medical department will drive medical research and development.

      3)3.Increase the hospital’s brand influence in China, this will also help raise cooperation between domestic and international organizations, as well as attract quality patient resources, which will lead to the growth in economic benefits. At the same time, according to “Several Opinions of the State Council on Promoting the Development of Health Service Industry”, the construction of Joint Molecular Centers is an historic opportunity, and said center can be appointed as the City’s Molecular Medical Center. Take the opportunity to become China’s Key Translational Medical Clinical Research Laboratory and Medical Big Data Cloud Computing Center to build an innovative medical model for research-oriented hospitals.

    2、Investors:

    Biotecan Industry Fund focuses on Medical Big Data and biotech companies that have potential high-added value. Please contact the Department of Innovative Business for more information.

    3、Government Officials and Civil Servants:

    Biotecan has now set up a joint venture -"City molecular diagnostic public service platform of Zaozhuang " with Zaozhuang Health Planning Commission, three things to be done,

      1)1.Construct Zaozhuang City Molecular Diagnostics Center by district and eventually undertake all of Zaozhuang City hospital’s high-class molecular diagnostics services, child health detection, tumor detection and related social welfare services.

      2)2.Luxury Zaozhuang Health and Management Center: Provide a comprehensive and integrated Precision Medical Care on all levels with the revolutionary technology of Whole Genome Sequencing (WGS), the leading hardware system in the world.

      3)3.Shanghai Zhangjiang-Zaozhuang Bioinformation Big Data Platform: The Cloud Computing Big Data Center will include the construction of Supercomputers, large-scale Medical Big Database and Automated Bioinformation Processing System. It aims to become a Province-Level Clinical and WGS Datacenter for Biotech’s Joint Molecular Medical Center.

    Zaozhuang Molecular Diagnostic Public Service Platform will become one of the most influential and continuous beneficial project, and will be a key factor that contributes to the upstream and downstream enterprises in the Biopharmaceutical Industry.

    The Healthcare Industry is thriving, and plays an important role in the economic development of Zaozhuang City. Using the “Industry-University-Research-Medical Collaboration” development model, Biotech will create a healthier nation by integrating resources and revolutionizing the future of healthcare industry in China.

    Please contact the Department of Innovative Business for more information.

    4、Doctors and Medical Professionals:

    In 2013, the Second Medical Military University, and the Shanghai Zhangjiang Translational Medical Research and Development Center has co-established a Translational Medical R&D Center, officially developing a Personalized Medical Big Data Platform concentrating on the research and treatment of tumor. In addition, they have co-built a national-level medical big data and an innovative biopharmaceutical industrialization system which has undertook national research projects, formed a personalized medical standard and demonstration zone, as well as the application and promotion of these projects. In 2014, they launched the scientific research collaboration on early detection of esophageal cancer and lung cancer, which is based on “Industry-University-Research-Medical Collaboration” development model and the Medical Big Data Cloud Computing Platform.

    Biotech has a unique multiunit technological research platform, which includes Metabolomics Analysis, Illumina High Throughput Sequencing, CTC Test, Protein Expression Profiling Analysis, ctDNA Research, MicroRNA Research Platform and such. As of 2016, Biotecan is partners with the Xiangya Hospital Central South University, Children’s Hospital Affiliated to the Capital Institute of Pediatrics, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hebei General Hospital, Shanghai Chest Hospital, Second Medical Military University, Changzheng Hospital, Eastern Hepatobiliary Surgery Hospital, The Gulou Hospital Affiliated to Nanjing University, and over 90 A-Level Hospitals. In the end of 2017, we aim to collaborate with over 200 hospitals and build China’s Precision Medical Big Data Network.

     

    Please contact the Medical Big Data Business Department for more information.

      1)1.Construct Zaozhuang City Molecular Diagnostics Center by district and eventually undertake all of Zaozhuang City hospital’s high-class molecular diagnostics services, child health detection, tumor detection and related social welfare services.

      2)2.Luxury Zaozhuang Health and Management Center: Provide a comprehensive and integrated Precision Medical Care on all levels with the revolutionary technology of Whole Genome Sequencing (WGS), the leading hardware system in the world.

      3)3.Shanghai Zhangjiang-Zaozhuang Bioinformation Big Data Platform: The Cloud Computing Big Data Center will include the construction of Supercomputers, large-scale Medical Big Database and Automated Bioinformation Processing System. It aims to become a Province-Level Clinical and WGS Datacenter for Biotech’s Joint Molecular Medical Center.

    Zaozhuang Molecular Diagnostic Public Service Platform will become one of the most influential and continuous beneficial project, and will be a key factor that contributes to the upstream and downstream enterprises in the Biopharmaceutical Industry.

    The Healthcare Industry is thriving, and plays an important role in the economic development of Zaozhuang City. Using the “Industry-University-Research-Medical Collaboration” development model, Biotech will create a healthier nation by integrating resources and revolutionizing the future of healthcare industry in China.

    Please contact the Department of Innovative Business for more information.

    4、Doctors and Medical Professionals:

    In 2013, the Second Medical Military University, and the Shanghai Zhangjiang Translational Medical Research and Development Center has co-established a Translational Medical R&D Center, officially developing a Personalized Medical Big Data Platform concentrating on the research and treatment of tumor. In addition, they have co-built a national-level medical big data and an innovative biopharmaceutical industrialization system which has undertook national research projects, formed a personalized medical standard and demonstration zone, as well as the application and promotion of these projects. In 2014, they launched the scientific research collaboration on early detection of esophageal cancer and lung cancer, which is based on “Industry-University-Research-Medical Collaboration” development model and the Medical Big Data Cloud Computing Platform.

    Biotech has a unique multiunit technological research platform, which includes Metabolomics Analysis, Illumina High Throughput Sequencing, CTC Test, Protein Expression Profiling Analysis, ctDNA Research, MicroRNA Research Platform and such. As of 2016, Biotecan is partners with the Xiangya Hospital Central South University, Children’s Hospital Affiliated to the Capital Institute of Pediatrics, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hebei General Hospital, Shanghai Chest Hospital, Second Medical Military University, Changzheng Hospital, Eastern Hepatobiliary Surgery Hospital, The Gulou Hospital Affiliated to Nanjing University, and over 90 A-Level Hospitals. In the end of 2017, we aim to collaborate with over 200 hospitals and build China’s Precision Medical Big Data Network.

     

    Please contact the Medical Big Data Business Department for more information.

  • Agent Productions Cooperation

    Contact: Mrs. Li

    Tel:021-50277725-3537

    Mail:mli@biotecan.com

    Address:No.180 Zhangheng Road, Pudong New District, Shanghai

    Brand Promotion and Media Cooperation

    Contact: Mrs. Li

    Tel:021-50277725-3537

    Mail:mli@biotecan.com

    Address:No.180 Zhangheng Road, Pudong New District, Shanghai

    Material and Diagnostic Reagent Cooperation

    Contact: Mrs. Ding

    Tel:021-50277725-3027

    Mail:fding@biotecan.com

    Address:No.180 Zhangheng Road, Pudong New District, Shanghai


  • Product Type

    • Stationary

    • Detection Reagent

    • Commonly Used Consumables

    • Instruments and Equipment

    • HPC/Data Center

    List of Product

    The opportunity is coming soon.

    Contacts

    Contacts:Hui Yan

    Tel:021-50277725-3568

    Email:hyan@biotecan.com

    Adress:180 Zhangheng Rd., Pudong New District, Shanghai

  • Contact Us
  • Shanghai Biotecan Pharmaceuticals Co. , Ltd.
  • Telephone:+86-21-50277725
  • Address

    First Shanghai Centre, 180 Zhangheng Rd., Pudong New District, Shanghai, China

Copyright © 2015-2018 Shanghai Biotecan Pharmaceuticals Co.,Ltd All Rights Reserved 沪ICP备09055310号-1 沪公网安备 31011502003232号